EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer

EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer

New prognostic factors and targeted therapies are urgently needed to improve therapeutic outcomes in vulvar cancer patients and to reduce therapy related morbidity. Previous studies demonstrated the important role of prostaglandin receptors in inflammation and carcinogenesis in a variety of tumor en...

Full description

Bibliographic Details
Main Authors: Anna Buchholz, Aurelia Vattai, Sophie Fürst, Theresa Vilsmaier, Christina Kuhn, Elisa Schmoeckel, Doris Mayr, Christian Dannecker, Sven Mahner, Udo Jeschke, Helene H. Heidegger
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
EP4
PGE2
COX-2
cancer survival
prognosis
vulvar carcinoma
Online Access:https://www.mdpi.com/2072-6694/13/6/1410

Similar Items

Similar Items